AVL-292 - CAS 1202757-89-8
Catalog number:
1202757-89-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
BTK
Description:
AVL-292, also known as CC-292, is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, AVL-292 targets and covalently binds to BTK, thereby preventing its activity.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white solid powder
Synonyms:
CC-292; CC292; CC 292; AVL292; AVL 292.
MSDS:
Inquire
Current Developer:
Avila Therapeutics, Inc.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related BTK Products


CAS 1202757-89-8 AVL-292

AVL-292
(CAS: 1202757-89-8)

AVL-292, also known as CC-292, is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplas...

CAS 1022150-12-4 Btk inhibitor 1 R enantiomer

Btk inhibitor 1 R enantiomer
(CAS: 1022150-12-4)

Btk inhibitor 1 R enantiomer is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.

CAS 1133432-49-1 GDC-0837

GDC-0837
(CAS: 1133432-49-1)

GDC-0834 is a small molecule inhibitor of Btk potentially useful in the treatment of RA and lymphoid malignancies. Administration of GDC-0834 (30 -- 100 mg/kg)...

ONO-4059 analogue
(CAS: 1351635-67-0)

ONO-4059 analogue is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.

ONO-4059 (hydrochloride)
(CAS: 1439901-97-9)

ONO-4059 (hydrochloride) is the hydrochloride salt form of Tirabrutinib. ONO-4059 is a highly selective, orally bioavailable BTK inhibitor (IC50= 2.2 nM) and de...

CAS 1133432-46-8 GDC-0834

GDC-0834
(CAS: 1133432-46-8)

GDC-0834 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis. In vitro metabol...

CAS 1360053-81-1 AVL-292 benzenesulfonate

AVL-292 benzenesulfonate
(CAS: 1360053-81-1)

AVL-292 benzenesulfonate is a covalent, highly selective, orally active small molecule inhibitor of Btk with IC50 value of 0.5 nM; >1400-fold selectivity ove...

CAS 1415823-73-2 Evobrutinib

Evobrutinib
(CAS: 1415823-73-2)

Evobrutinib is a highly selective inhibitor of Bruton's tyrosin kinase (Btk) inhibitor.

CAS 910232-84-7 CGI1746

CGI1746
(CAS: 910232-84-7)

CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exqui...

RN983
(CAS: 1423129-83-2)

RN983 is a selective BTK enzyme inhibitor. It inhibits IgG production in B-cells with an IC50 value of 2.5 ± 0.7 nM and PGD2 production from mast cells with an ...

CAS 330786-25-9 PCI 29732

PCI 29732
(CAS: 330786-25-9)

Potent BTK inhibitor (IC50 = 0.3 nM). Blocks B cell antigen receptor (BCR)-mediated gene expression in CD20+ B cells.

CAS 1353550-13-6 Olmutinib

Olmutinib
(CAS: 1353550-13-6)

Olmutinib, also called as HM61713 and BI-1482694, is an orally available, mutant-selective third-generation epidermal growth factor receptor tyrosine kinase inh...

CAS 1633350-06-7 BGB-3111

BGB-3111
(CAS: 1633350-06-7)

BGB-3111 is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor that demonstrates superior oral bioavailability, achieving higher ...

CAS 1469988-75-7 QL47

QL47
(CAS: 1469988-75-7)

QL47 is a potent and selective BTK inhibitor, which covalently modifies Cys481. QL47 inhibits BTK kinase activity with an IC50 of 7 nM, inhibits autophosphoryla...

ONO-4059
(CAS: 1351636-18-4)

ONO-4059, a BTK inhibitor, has been found to have potential effect against sorts of malignancies by influencing the B-cell development. It is currently under Ph...

CAS 1242156-23-5 RN486

RN486
(CAS: 1242156-23-5)

RN486 is a reversible Bruton's tyrosine kinase (Btk) inhibitor with IC50 value of 4.0 nM.

CAS 1553977-42-6 Btk inhibitor 1 R enantiomer hydrochloride

Btk inhibitor 1 R enantiomer hydrochlori
(CAS: 1553977-42-6)

Btk inhibitor 1R enantiomer Hcl is a&nbsp; pyrazolo[3,4-d]pyrimidine derivative as a <strong>Btk </strong>kinase inhibitor.

CAS 936563-96-1 PCI-32765 (Ibrutinib)

PCI-32765 (Ibrutinib)
(CAS: 936563-96-1)

Ibrutinib is a small-molecule inhibitor of Bruton's tyrosine kinase (BTK). It binds to BTK to suppress both B-cell activation and B-cell-mediated signaling.

CAS 1412418-47-3 Btk inhibitor 1

Btk inhibitor 1
(CAS: 1412418-47-3)

Btk inhibitor 1 is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.

Acalabrutinib (ACP-196)
(CAS: 1420477-60-6)

Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity.ACP-196 inhibits...

Chemical Structure

CAS 1202757-89-8 AVL-292

Quick Inquiry

Verification code

Featured Items